Conditional mutagenesis by cell-permeable proteins: Potential, limitations and prospects

Handbook of Experimental Pharmacology

Volumn 178, Issue , 2007, Pages 203-232

  Patsch, C ^a   Edenhofer, F ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Endocytosis; Gene therapy; Protein therapy; Protein transduction; Site specific recombination

Indexed keywords

DNA POLYMERASE; SITE SPECIFIC RECOMBINASE; SITE-SPECIFIC RECOMBINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE PERMEABILITY; CHEMISTRY; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; PROTEIN TERTIARY STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE PERMEABILITY; DNA NUCLEOTIDYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN STRUCTURE, TERTIARY; TRANSDUCTION, GENETIC;

EID: 33846903111     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-35109-2_9     Document Type: Review

References (115)

1. Astriab-Fisher A, Sergueev DS, Fisher M, Shaw BR, Juliano RL (2000) Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem Pharmacol 60:83-90
2. Becker-Hapak M, McAllister SS, Dowdy SF (2001) TAT-mediated protein transduction into mammalian cells. Methods 24:247-256
3. Belting M, Persson S, Fransson LA (1999) Proteoglycan involvement in polyamine uptake. Biochem J 338:317-323
4. Bode J, Schlake T, Iber M, Schubeler D, Seibler J, Snezhkov E, Nikolaev L (2000) The transgeneticist's toolbox: novel methods for the targeted modification of eukaryotic genomes. Biol Chem 381:801-813
5. Bolton SJ, Jones DN, Darker JG, Eggleston DS, Hunter AJ, Walsh FS (2000) Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain. Eur J Neurosci 12:2847-2855
6. Branda CS, Dymecki SM (2004) Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6:7-28
7. Brooks H, Lebleu B, Vives E (2005) Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57:559-577
8. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT, Jung S, Waisman A (2005) A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2:419-426
9. Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, Bresolin N, Tremblay JP (2001) Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther 3:310-318
10. Caron NJ, Quenneville SP,Tremblay JP (2004) Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun 319:12-20
11. Cohen-SaidonC,NechushtanH,Kahlon S, Livni N,Nissim A, Razin E (2003) Anovel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood 102:2506-2512
12. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37-44
13. Console S, Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K (2003) Antennapedia and HIV transactivator of transcription (TAT) protein transduction domains promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278:35109-35114
14. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP (1998) Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible formof Cre recombinase. Curr Biol 8:1323-1326
15. Demuth I, Frappart PO, Hildebrand G, Melchers A, Lobitz S, Stockl L, Varon R, Herceg Z, Sperling K, Wang ZQ, Digweed M (2004) An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet 13:2385-2397
16. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269:10444-10450
17. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188-18193
18. Derossi D, Chassaing G, Prochiantz A (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 8:84-87
19. Dietz GP, Bahr M (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 27:85-131
20. DostmannWR, TaylorMS, Nickl CK, Brayden JE, Frank R, TeggeWJ (2000) Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci U S A 97:14772-14777
21. Elliott G, O'Hare P (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223-233
22. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR,Wei MC, Dowdy SF (1997) Hypophosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A 94:10699-10704
23. Falnes PO, Wesche J, Olsnes S (2001) Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. Biochemistry 40:4349-4358
24. Fang B, Xu B, Koch P, Roth JA (1998) Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther 5:1420-1424
25. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 91:664-668
26. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93:10887-10890
27. Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giacca M, Beltram F (2003) Caveolaemediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther 8:284-294
28. Fittipaldi A, Ferrari A, Zoppe M, Arcangeli C, Pellegrini V, Beltram F, Giacca M (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem 278:34141-34149
29. Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193
30. Fuhrmann-BenzakeinE,Garcia-Gabay I,PepperMS,VassalliJD,HerreraPL (2000) Inducible and irreversible control of gene expression using a single transgene. Nucleic Acids Res 28:e99
31. Ghibaudi E, Boscolo B, Inserra G, Laurenti E, Traversa S, Barbero L, Ferrari RP (2005) The interaction of the cell-penetrating peptide penetratin with heparin, heparansulfates and phospholipid vesicles investigated by ESR spectroscopy. J Pept Sci 11:401-409
32. GiusDR, Ezhevsky SA,Becker-Hapak M,Nagahara H,WeiMC,Dowdy SF (1999) Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res 59:2577-2580
33. Glover S, Nathaniel R, Shakir L, Perrault C, Anderson RK, Tran-Son-Tay R, Benya RV (2005) Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling. Am J Physiol Gastrointest Liver Physiol 288:G1274-G1282
34. Green I, Christison R, Voyce CJ, Bundell KR, Lindsay MA (2003) Protein transduction domains: are they delivering? Trends Pharmacol Sci 24:213-215
35. Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179-1188
36. Gu H,Marth JD, Orban PC,Mossmann H, Rajewsky K (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103-106
37. Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F, Tavassoli M (2004) TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23:1153-1165
38. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, WisslerM, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419
39. Hakkarainen T, Wahlfors T, Merilainen O, Loimas S, Hemminki A, Wahlfors J (2005) VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct. J Gene Med 7:898-907
40. Han K, JeonMJ, Kim SH, Ki D, Bahn JH, Lee KS, Park J, Choi SY (2001) Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol Cells 12:267-271
41. Haupt S, Edenhofer F, Peitz M, Leinhaas A, Brustle O (2006) Stage specific conditional mutagenesis inmouseembryonic stemcell-derived neural cells andpost-mitotic neurons by direct delivery of biologically active Cre recombinase. Stem Cells. 2006 Sep 7; [Epub ahead of print]
42. Heng BC, Cao T (2005) Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody) . Med Hypotheses 64:1105-1108
43. Ho A, Schwarze SR,Mermelstein SJ,Waksman G, Dowdy SF (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 61:474-477
44. Hoess RH, Ziese M, Sternberg N (1982) P1 site-specific recombination: nucleotide sequence of the recombining sites. Proc Natl Acad Sci U S A 79:3398-3402
45. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH (2003) Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 4:321-329
46. JoD,Nashabi A,Doxsee C, LinQ,UnutmazD, Chen J, RuleyHE (2001) Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 19:929-933
47. Joshi SK, Hashimoto K, Koni PA (2002) Induced DNA recombination by Cre recombinase protein transduction. Genesis 33:48-54
48. Kabouridis PS (2003) Biological applications of protein transduction technology. Trends Biotechnol 21:498-503
49. Kaplan IM, Wadia JS, Dowdy SF (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102:247-253
50. Kellendonk C, Tronche F, Casanova E, Anlag K, Opherk C, Schutz G (1999) Inducible sitespecific recombination in the brain. J Mol Biol 285:175-182
51. Kondo M, Asai T, Katanasaka Y, Sadzuka Y, Tsukada H, Ogino K, Taki T, Baba K, Oku N (2004) Anti-neovascular therapy by liposomal drug targeted tomembrane type-1 matrix metalloproteinase. Int J Cancer 108:301-306
52. Kracker S, Bergmann Y, Demuth I, Frappart PO, Hildebrand G, Christine R, Wang ZQ, Sperling K, Digweed M, Radbruch A (2005) Nibrin functions in Ig class-switch recombination. Proc Natl Acad Sci U S A 102:1584-1589
53. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G (2003) In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 9:1428-1432
54. Kuhn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269:1427-1429
55. Kuzin II, Snyder JE, Ugine GD, Wu D, Lee S, Bushnell T Jr, Insel RA, Young FM, Bottaro A (2001) Tetracyclines inhibit activated B cell function. Int Immunol 13:921-931
56. Kwon YD, Oh SK, Kim HS, Ku SY, Kim SH, Choi YM,Moon SY (2005) Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Mol Ther 12:28-32
57. LaksoM, Sauer B,Mosinger B Jr, Lee EJ,Manning RW, Yu SH,Mulder KL,WestphalH (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A 89:6232-6236
58. Leifert JA, Harkins S, Whitton JL (2002) Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther 9:1422-1428
59. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2:743-755
60. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410-414
61. Lin Q, Dong C, Cooper MD (1998) Impairment of T and B cell development by treatment with a type I interferon. J Exp Med 187:79-87
62. Lin Q, Jo D, Gebre-Amlak KD, Ruley HE (2004) Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells. BMC Biotechnol 4:25
63. Lin YZ,Yao SY,VeachRA,TorgersonTR,Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membranepermeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258
64. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ (2000) Uptake ofHIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6:1380-1387
65. Logie C, Stewart AF (1995) Ligand-regulated site-specific recombination. Proc Natl Acad Sci U S A 92:5940-5944
66. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, Jonkers J (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A 98:9209-9214
67. Lundberg M, Johansson M (2001) Is VP22 nuclear homing an artifact? Nat Biotechnol 19:713-714
68. Madore SJ, Cullen BR (1993) Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol 67:3703-3711
69. Mai JC, Shen H,Watkins SC, Cheng T, Robbins PD (2002) Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem 277:30208-30218
70. Matsushita M, Tomizawa K,Moriwaki A, Li ST, Terada H,Matsui H (2001) A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci 21:6000-6007
71. Matsushita M, Noguchi H, Lu YF, Tomizawa K, Michiue H, Li ST, Hirose K, Bonner-Weir S, Matsui H (2004) Photo-acceleration of protein release from endosome in the protein transduction system. FEBS Lett 572:221-226
72. McLeodM,Craft S,Broach JR (1986) Identificationof the crossover siteduringFLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle. Mol Cell Biol 6:3357-3367
73. Metzger D, Clifford J, Chiba H, Chambon P (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. ProcNatl Acad Sci U S A 92:6991-6995
74. Minamino T, Gaussin V, DeMayo FJ, Schneider MD (2001) Inducible gene targeting in postnatalmyocardium by cardiac-specific expression of a hormone-activated Cre fusion protein. Circ Res 88:587-592
75. Mortlock A, Low W, Crisanti A (2003) Suppression of gene expression by a cell-permeable Tet repressor. Nucleic Acids Res 31:e152
76. Murakami M, Ichisaka T,Maeda M, Oshiro N, Hara K, Edenhofer F, Kiyama H, Yonezawa K, Yamanaka S (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24:6710-6718
77. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-HapakM, Ezhevsky SA, Dowdy SF (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4:1449-1452
78. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109
79. Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, Koike Y, Takehashi M, Tanaka S, Ueda K, Simpson JC, JonesAT, Sugiura Y, Futaki S (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10:1011-1022
80. Narita M, Bu G, Olins GM,Higuchi DA,Herz J, Broze GJ Jr, Schwartz AL (1995) Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo. J Biol Chem 270:24800-24804
81. Nolden L, Edenhofer F, Haupt S, Koch P,Wunderlich FT, Siemen H, Brustle O. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods. 2006 Jun;3 (6) 461-7
82. Oberdoerffer P, Otipoby KL,Maruyama M, Rajewsky K (2003) Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71. Nucleic Acids Res 31:e140
83. Orban PC, Chui D, Marth JD (1992) Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 89:6861-6865
84. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F (2002) Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A 99:4489-4494
85. Pooga M, Hallbrink M, ZorkoM, Langel U (1998) Cell penetration by transportan. FASEB J 12:67-77
86. Prochiantz A (2000) [Messenger proteins]. J Soc Biol 194:119-123
87. Rajewsky K, Gu H, Kuhn R, Betz UA, MullerW, Roes J, Schwenk F (1996) Conditional gene targeting. J Clin Invest 98:600-603
88. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585-590
89. RichardJP,Melikov K,Brooks H,PrevotP,LebleuB, ChernomordikLV (2005) Cellularuptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280:15300-15306
90. Rohlmann A, Gotthardt M,Willnow TE, Hammer RE, Herz J (1996) Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat Biotechnol 14:1562-1565
91. Sadowski PD (1995) The Flp recombinase of the 2-microns plasmid of Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 51:53-91
92. Sandgren S,Wittrup A, Cheng F, JonssonM, Eklund E, Busch S, BeltingM (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279:17951-17956
93. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572
94. Schwarze SR, Hruska KA, Dowdy SF (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 10:290-295
95. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I,Nakamura Y, Shiba K,Noda T (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278:120-123
96. SilholM, TyagiM, Giacca M, Lebleu B, Vives E (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 269:494-501
97. Silver DP, Livingston DM (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8:233-243
98. Sun J, Tumurbaatar B, Jia J, Diao H, Bodola F, Lemon SM, Tang W, Bowen DG, Mc-Caughan GW, Bertolino P, Chan T-S (2005) Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. J Virol 79:10730-10739
99. SuzukiT, Futaki S,NiwaM,Tanaka S,Ueda K, SugiuraY (2002) Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 277:2437-2443
100. Takenobu T, Tomizawa K, Matsushita M, Li ST, Moriwaki A, Lu YF, Matsui H (2002) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells. Mol Cancer Ther 1:1043-1049
101. Torchilin VP, Rammohan R,Weissig V, Levchenko TS (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 98:8786-8791
102. Tung CH, Weissleder R (2003) Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 55:281-294
103. Tünnemann G, Martin RM, Haupt S, Patsch C, Edendorfer F, Cardoso MC (2006) Cargodependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 2006 Sep;20 (11) :1775-84
104. Tyagi M, Rusnati M, Presta M, Giacca M (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276:3254-3261
105. Tze LE, Schram BR, Lam KP, Hogquist KA, Hippen KL, Liu J, Shinton SA, Otipoby KL, Rodine PR,Vegoe AL, KrausM,Hardy RR, Schlissel MS, Rajewsky K, Behrens TW (2005) Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol 3:e82
106. Utomo AR, Nikitin AY, Lee WH (1999) Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat Biotechnol 17:1091-1096
107. Vasioukhin V, Degenstein L, Wise B, Fuchs E (1999) The magical touch: genome targeting in epidermal stemcells induced by tamoxifen application tomouse skin. Proc Natl Acad Sci U S A 96:8551-8556
108. Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010-16017
109. Wadia JS, Dowdy SF (2003) Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci 4:97-104
110. Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310-315
111. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97:13003-13008
112. Will E,KlumpH, HeffnerN, SchwiegerM, Schiedlmeier B, OstertagW, BaumC, StockingC (2002) Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res 30:e59
113. Williams EJ, Dunican DJ, Green PJ, Howell FV, Derossi D, Walsh FS, Doherty P (1997) Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide. J Biol Chem 272:22349-22354
114. Yu BD, Becker-Hapak M, Snyder EL, Vooijs M, Denicourt C, Dowdy SF (2003) Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc Natl Acad Sci U S A 100:14881-14886
115. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A (2001) p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2:27-34